Список литературы.

1. Loeser J.D., Arendt-Nielsen L., Baron R., Basbaum A., Bond M., Breivik H., Clauw D., De Laat A., Dworkin R., Giamberardino M. A., Goadsby P., Haanpaa M., Okifuji A., Paice J., Woda A. Classification of Chronic Pain, Second Edition (Revised). Доступно по ссылке: http://www.iasp- pain.org/PublicationsNews/Content.aspx?ItemNumber=1673.

2. Яхно Н.Н., Кукушкин М.Л., Данилов А.Б., Амелин А.В., Давыдов О.С., Куликов С.М. Результаты российского эпидемиологического исследования распространенности невропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу неврологу. Российский журнал боли. 2008; 3 (20): 24-32.

3. Rasu R.S., Vouthy K., Crowl A.N., Stegeman A.E., Fikru B., Bawa W.A., Knell M.E. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. Journal of managed care and speciality pharmacy. 2014; 20(9): 921-928.

4. Cruccu G., Sommer C., Anand P., Attal N., Baron R., Garcia-Larrea L., Haanpaa M., Jensena T. S., Serraa J., Treedek R.-D. EFNS guidelines on neuropathic pain assessment: revised 2009. European Journal of Neurology 2010, 17: 1010-1018. doi:10.1111/j.1468-1331.2010.02969.x.

5. Torrance N., Ferguson J.A, Afolabi E., Bennett M.I., Serpell M.G., Dunn K.M., Smith B.H. Neuropathic pain in the community: More under-treated than refractory? Pain. 2013; 154: 690-699. doi: 10.1016/j.pain.2012.12.022.

6. Чурюканов М. В., Дорохов Е. В. Фармакорезистентная нейропатическая боль. Неврология, нейропсихиатрия, психосоматика. 2013; 2: 84-88.

7. Исагулян Э.Д. Хроническая электростимуляция спинного и головного мозга в лечении нейрогенных болевых синдромов. - Дис канд. мед. наук. Москва; 2006. Доступно по: http://elibrary.ru/item.asp?id=16201433 или http://dlib.rsl.ru/01004299840. Ссылки активны на 28.07.2015.

8. Исагулян Э. Д., Шабалов В. А. Хирургическое лечение нейропатических болевых синдромов. Часть 1. Нейрохирургия. 2009; 2: 5-12.

9. Исагулян Э. Д., Шабалов В. А. Методы нейростимуляции в лечении боли. Manage Pain. 2014; 4: 48-54.

10. Cruccu G., Aziz T.Z., Garcia-Larrea L., Hansson P., Jensen T.S., Lefaucheur J.-P., Simpson B.A., Taylor R.S. EFNS guidelines on neurostimulation therapy for neuropathic pain. European Journal of Neurology 2007. 14: 952-970. doi:10.1111/j.1468-1331.2007.01916.x.

11. Reverberi C., Dario A., Barolat G., Zuccon G. Using peripheral nerve stimulation (PNS) to treat neuropathic pain: a clinical series. Neuromodulation. 2014; 17(8): 777-783. doi: 10.1111/ner.12157.

12. Petersen E.A., Slavin K.V. Peripheral nerve/field stimulation for chronic pain. Neurosurgery clinics of North America. 2014; 25(4): 789-797. doi: 10.1016/j.nec.2014.07.003.

13. Kloimstein H., Likar R., Kern M., Neuhold J., Cada M., Loinig N., Ilias W., Freundl B., Binder H., Wolf A., Dorn C., Mozes-Balla E.M., Stein R., Lappe I., Sator-Katzenschlager S. Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study. Neuromodulation. 2014; 17(2): 180-187. doi: 10.1111/ner.12139.

14. Lipov E.G. Hybrid neurostimulator: simultaneous use of spinal cord and peripheral nerve field stimulation to treat low back and leg pain. Progress in neurological surgery. 2011; 24: 147-155. doi: 10.1159/000323047.

15. Исагулян Э. Д., Шабалов В. А. Хроническая электростимуляция спинного мозга в лечении синдрома оперированного позвоночника. Хирургия позвоночника. 2014; 4: 41-48.

16. Wolter T. Spinal cord stimulation for neuropathic pain: current perspectives. Journal of Pain Research. 2014; 7: 651 - 663. doi.: 0.2147/JPR.S37589.

17. Dworkin R.H., O’Connor A.B., Kent J., Mackey S.C., Raja S.N., Stacey B.R., Levy R.M., Backonja M., Baronh R., Harke H., Loeser J.D., Treede R.-D., Turk D.C., Wells C.D. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013; 154 (11): 2249-2261. doi:10.1016/j.pain.2013.06.004.

18. Сафин А.В., Бобровская А.Н., Исагулян Э.Д., Дуров О.В., Ларин А.И. Опыт применения постоянной электростимуляции сакрального сплетения для купирования у женщины нейрогенной хронической тазовой боли. Клиническая практика. 2013;1(13): 31-36.

19. Valovska A., Peccora C.D, Philip C.N., Kaye A.D., Urman R.D. Sacral neuromodulation as a treatment for pudendal neuralgia. Pain Physician. 2014; 17(5): E645-E650.

20. Peters K.M. Neuromodulation for the treatment of refractory interstitial cystitis. Reviews in urology. 2002; 4 Suppl. 1: 36-43.

21. Tirlapur S.A., Vlismas A., Ball E., Khan K.S. Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta obstetrica et gynecologica Scandinavica. 2013; 92(8): 881-887. doi: 10.1111/aogs.12184.

22. Norderval S., Rydningen M., Lindsetmo R.O., Lein D., Vonen B. Sacral nerve stimulation. Tidsskrift for den Norske laegeforening. 2011; 131(12): 11901193. doi: 10.4045/tidsskr.10.1417.

23. Kim J.H., Hong J.C., Kim M.S., Kim S.H. Sacral nerve stimulation for treatment of intractable pain associated with cauda equina syndrome. Journal of Korean Neurosurgical Society. 2010; 47(6): 473-476. doi: 10.3340/jkns.2010.47.6.473.

24. Исагулян Э.Д., Шабалов В.А. Хирургическое лечение центральных болевых синдромов. Нейрохирургия. 2009; 3: 8-16.

25. Sukul V.V., Slavin K.V. Deep Brain and Motor Cortex Stimulation. Current Pain and Headache Reports. 2014; 18(7): 427. doi: 10.1007/s11916-014-0427-2.

26. Nguyen J.P., Nizard J., Keravel Y., Lefaucheur J,P. (2011). Invasive brain stimulation for the treatment of neuropathic pain. Nature Reviews Neurology. 2011; 7(12): 699-709. doi: 10.1038/nrneurol.2011.138.

27. Rasche D., Ruppolt M., Stippich C., Unterberg A., Tronnier V.M. Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10-year experience. Pain. 2006; 121(1-2): 43-52.

28. Nguyen J.P., Velasco F., Brugieres P., Velasco M., Keravel Y., Boleaga B., Brito F., Lefaucheur JP. Treatment of chronic neuropathic pain by motor cortex stimulation: results of a bicentric controlled crossover trial. Brain Stimulation. 2008; 1(2): 89-96. doi: 10.1016/j.brs.2008.03.007.

29. Velasco F., Arguelles C., Carrillo-Ruiz J.D., Castro G., Velasco A.L., Jimenez F., Velasco M. Efficacy of motor cortex stimulation in the treatment of neuropathic pain: a randomised double-blind trial. Journal Of Neurosurgery. 2008; 108(4):698-706. doi: 10.3171/JNS/2008/108/4/0698.

30. Lefaucheur J.P., Drouot X., Cunin P., Bruckert R., Lepetit H., Creange A, Wolkenstein P., Maison P., Keravel Y., Nguyen J.P. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. Brain. 2009; 132(6): 1463-1471. doi: 10.1093/brain/awp035.

31. Lima M.C., Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008; 70(24): 2329-2337. doi: 10.1212/01.wnl.0000314649.38527.93.

32. Fontaine D., Hamani C., Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. Journal Of Neurosurgery. 2009; 110(2): 251-256. doi: 10.3171/2008.6.17602.

33. Deer T., Winkelmuller W., Erdine S., Bedder M., Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation, 1999, 2 (2): 55-66.

34. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002 Oct 1;20(19):4040-9.

35. Smith H.S., Deer T.R., Staats P.S., Singh V., Sehgal N., Cordner H. Intrathecal drug delivery. Pain Physician. 2008. 11(2 Suppl): 89-104.

36. The British Pain Society. Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice, www.britishpainsociety.org. Доступно по ссылке: www.britishpainsociety.org/book ittd main.pdf (accessed 5 February 2012).

37. Deer T.R, Prager J., Levy R., Rathmell J., Buchser E., Burton A., Caraway D., Cousins M., De Andres J., Diwan S., Erdek M., Grigsby E., Huntoon M., Jacobs M.S., Kim P., Kumar K., Leong M., Liem L., McDowell G.C. 2nd, Panchal S,. Rauck R., Saulino M., Sitzman B.T., Staats P., Stanton-Hicks M., Stearns L., Wallace M., Willis K.D., Witt W., Yaksh T., Mekhail N. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012; 15(5): 436-64; doi: 10.1111/j.1525-1403.2012.00476.x.

38. Smith HS, Deer TR. Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain. Therapeutics and clinical risk management. 2009; 5(3): 521-534.

39. Farquhar-Smith P. Neuraxial (epidural and intrathecal) infusions I: Anatomy and commonly used drugs: mode of action, pharmacokinetics, side effects and evidence base for effectiveness. In: Hester J., Sykes N. and Peat S. (eds) Interventional pain control in cancer pain management. Oxford: Oxford University Press, 2011, pp. 58-81.

40. Ackerman L.L., Follett K.A., Rosenquist R.W. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage. 2003; 26 (1): 668-677.